Growth factors and transforming proteins that activate tyrosine phosphorylation have been shown to cause an increased labeling of 3-phosphate-containing phosphatidylinositols. Turnover correlates with the formation of a complex between phosphatidylinositol 3-kinase, the activated protein-tyrosine kinase, and other proteins thought to participate in transmembrane signaling. When human platelets are treated with thrombin, labeling of 3-phosphate-containing phosphatidylinositols is stimulated with a time course and concentration dependence consistent with a role for these lipids in platelet activation. We now report that when human platelets are stimulated with thrombin, a complex forms between phosphatidylinositol 3-kinase, a protein-serine/threonine kinase, and an uncharacterized platelet membrane protein. The complex is immunoprecipitated from detergent lysates ofthrombinstimulated platelets by a rabbit antiserum prepared against a peptide from the cytoplasmic domain of the mouse plateletderived growth factor (PDGF) receptor. The antigen is not the PDGF receptor, since complex formation is not stimulated by PDGF and thrombin-induced complexes are not precipitated by another rabbit antiserum against the same peptide or by monoclonal anti-human PDGF receptor antibodies. Formation of the complex is rapid (within 30 sec) and occurs at thrombin concentrations that stimulate platelet aggregation and secretion (50% of maximal complex formation at 0.03 unit of thrombin per ml). We propose that the complex initiates formation of3-phosphate-containing phosphatidylinositols that may function in platelet activation.
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An early event in thrombin-induced platelet activation is hydrolysis of phosphatidylinositols by phospholipase C. The substrates cleaved include phosphatidylinositol (PtdIns), phosphatidylinositol 4-phosphate [Ptdlns(4)P], and phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2]. Products of this reaction participate in protein kinase C activation, calcium mobilization, and production of icosanoid mediators (1) (2) (3) (4) (5) (6) (7) .
An alternative PtdIns pathway was recently identified in fibroblasts (8, 9) , neutrophils (10) , vascular smooth muscle cells (11) , astrocytoma cells (12) , and platelets (13) . PtdIns 3-kinase initiates the pathway by phosphorylating PtdIns to produce Ptdlns(3)P. Further phosphorylated forms of 3-phosphate-containing lipids have also been discovered, including PtdIns(3,4)P2 and PtdIns (3, 4, 5) P3 (14) (15) (16) (17) (18) . The identity and structure of PtdIns(3)P, PtdIns(3,4)P2, and Ptdlns(3,4,5)P3 have recently been determined in platelets (54) . These lipids are labeled rapidly upon thrombin stimulation, suggesting that they may be important in platelet activation (13, 18) . Ptdlns 3-kinase activity has been shown to associate with growth factor receptors and oncoproteins containing tyrosine kinase activity. These include the polyoma virus middle T antigen/pp60c-src complex (19, 20) , pp604-src in Rous sarcoma virus-transformed cells (21) , the platelet-derived growth factor (PDGF) receptor (22) , the colony-stimulating factor 1 receptor (16) , and the epidermal growth factor receptor (23) . Mutant forms of the PDGF receptor that are defective in mediating cell proliferation in response to PDGF fail to associate with PtdIns 3-kinase, suggesting that association with Ptdlns 3-kinase is essential for cell proliferation (22, 24) . Recent studies have demonstrated that Ptdlns 3-kinase may form part of a multiprotein complex that includes the activated PDGF receptor, the serine/threonine kinase Raf-1 (25), phospholipase C-y (26, 27) , and the GTPase-activating protein GAP (28) .
PtdIns 3-kinase-containing complexes have not been found in platelets. We now demonstrate such a complex containing PtdIns 3-kinase, a protein-serine/threonine kinase, and an uncharacterized platelet membrane protein. "To whom reprint requests should be addressed.
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were incubated with 32Pi (1 mCi/ml) for 1 hr at room temperature. Stimulation with thrombin was for 3 min at 370C.
Immunoprecipitation. Platelets were sedimented by centrifugation for 10 sec and immediately lysed at a concentration of 1010 platelets per ml in RIPA buffer (20 mM Tris, pH 7.4/50 mM NaCl/50 mM NaF/5 mM EDTA/20 mM sodium pyrophosphate/1 mM phenylmethylsulfonyl fluoride/1 mM sodium orthovanadate/1% Triton X-100). After 25 min on ice the supernatant was clarified by centrifugation and incubated 2-12 hr with antiserum at 40C. Immunoprecipitation reaction mixtures contained 1-4 x 108 platelets per 10-40 Al of antiserum A, antiserum E, or nonimmune serum. After incubation with protein A-Sepharose for 1 hr, the immunoprecipitates were washed three times at 40C with RIPA buffer and then three times with 100 mM NaCI/10 mM Tris, pH 7.4.
Ptdlns Kinase Assay. Washed protein A pellets were incubated in 100 ,A in the presence of 20 mM Tris (pH 7.5), 10 mM MgCI2, 5 mM EGTA, 20 ,g of sonicated PtdIns, 1 ,M ATP, and 10 ,uCi of [y 32P]ATP for 25 min at room temperature. The assay was linear over this time. Labeled phospholipids were extracted, separated by TLC, and detected by autoradiography (37) .
Silica gel was scraped from TLC plates and phospholipids were deacylated with methylamine. An internal standard of Ptd[3H]Ins(4)P was then added and lipids were characterized by HPLC as described (38) .
In Vitro Protein Kinase Assay. Protein kinase assays were performed on immunoprecipitates just as PtdIns kinase assays except that the reactions were stopped with the addition of SDS/2-mercaptoethanol sample buffer. After SDS/7.5% PAGE (39), the dried gels were subjected to autoradiography.
Other Methods. Proteins phosphorylated in vitro or in platelets were localized by autoradiography, excised from the gel, and subjected to SDS/12.5% PAGE in the presence of Staphylococcus aureus V8 protease (Miles) according to Cleveland et al. (40) . Phosphorylated proteins were extracted from SDS/polyacrylamide gels and precipitated with 20% (wt/vol) trichloroacetic acid, and phospho amino acids were analyzed as described by Lou and Schulman (41).
RESULTS
We initially investigated whether PtdIns 3-kinase activity was altered following thrombin treatment of platelets. Washed human platelets were treated with thrombin (2 units/ml) for 3 min and solubilized in RIPA buffer. PtdIns kinase assays were performed in 0.001% Triton X-100, which does not inhibit platelet PtdIns 3-kinase. Total PtdIns kinase activity was the same in thrombin-stimulated and unstimulated platelets, with no change in the proportions of Ptdlns(4)P and Ptdlns(3)P products.
Since platelets have been reported to have small numbers of PDGF receptors (42) and this receptor forms complexes with PTdIns 3-kinase, we attempted to immunoprecipitate PtdIns 3-kinase by using antisera raised against PDGF receptors. Rabbit anti-PDGF receptor antiserum A precipitated PtdIns kinase activity. In numerous experiments analyzed only by measuring the PtdInsP produced by immunoprecipitated PtdIns kinase and isolated by chromatography on TLC plates, we found that immunoprecipitates of lysates from thrombin-stimulated platelets had 2-to 17-fold increased PtdIns kinase activity compared with immunoprecipitates from unstimulated cells. The PtdInsP products were analyzed by deacylation of the lipids and separation of glycerophosphoinositols by HPLC (Fig. 1) precipitate thrombin-treated cells contained >90% PtdIns-(3)P with 6-fold increased PtdIns 3-kinase activity. In three other experiments PtdInsP products were deacylated and the glycerophosphoroinositols were analyzed. We found little or no Ptdlns(3)P in immunoprecipitates with nonimmune serum, somewhat variable amounts in unstimulated platelets with immune serum A, and 4-fold increased PtdIns 3-kinase activity precipitated from thrombin-treated platelet lysates with >90% Ptdlns(3)P in each case. PtdIns 3-kinase activity immunoprecipitated by antiserum A represented <5% of the total PtdIns 3-kinase activity measured in whole cell lysates.
Immunoprecipitations performed on Iysates from control and thrombin-treated platelets using antisera against other platelet antigens did not immunoprecipitate PtdIns kinase activity. These included polyclonal antisera against glycoproteins GPIIb and GPIIIa (43) and monoclonal antisera against the insulin-like growth factor I receptor (44) and insulin receptor (45) .
Thrombin Dependence of Immunoprecipitation. Studies of the time course and concentration-dependence of thrombinstimulated PtdIns kinase immunoprecipitation demonstrated that formation of complexes occurred in parallel with thrombin-induced platelet activation. Nearly maximal complex formation was seen within 30 sec of thrombin addition, and complexes persisted for at least 10 min (data not shown). Complex formation was half-maximal with thrombin at 0.03 unit/ml (Fig. 2) . These responses are similar to those found when measuring other parameters of thrombin-dependent platelet activation.
In Vitro Protein Kinase Assay of Immunoprecipitates. Other studies have shown that PtdIns 3-kinase forms complexes with receptors or oncoproteins that have intrinsic proteintyrosine kinase activity (16, (21) (22) (23) (Fig. 3, lanes 7 and 8) . As one of the major proteins phosphorylated in vitro in platelet membranes (46) , the presence of a 60-kDa phosphorylated protein in immunoprecipitates with antiserum A suggested that this protein might be pp60c-src. In vitro protein kinase reactions on immunoprecipitates of platelet lysates prepared using a monoclonal antibody against pp60C-src (Mab 327) are shown in lane 5. Note that the 60-kDa phosphorylated protein from antiserum A immunoprecipitates migrates slightly faster than pp60c-src. Partial V8 proteolytic peptide maps showed that the 60-kDa phosphoprotein immunoprecipitated by antiserum A was distinctly different from pp60csrc (Fig. 4) Fig. 3) ; lanes 2, 4, and 6, pp6O band (from lanes 7 and 8 of Fig.  3 ).
with antiserum A, indicating that the 60-kDa phosphoprotein immunoprecipitated by antiserum A is not one of these src-like proteins. Anti-pp60csrc Mab 327 did not detect pp60C-src when the antiserum A immunoprecipitates containing both thrombin-stimulated Ptdlns 3-kinase activity and protein-serine/threonine kinase activity were probed in an immunoblot assay. Phospho amino acid analysis of the 60-kDa protein phosphorylated in protein kinase assays of antiserum A immunoprecipitates showed primarily phosphothreonine and no phosphotyrosine (Fig. 5) .
We also labeled intact platelets with 32p,, treated them with thrombin, and immunoprecipitated extracts from the cells with antiserum A (Fig. 6A) . The major phosphoprotein immunoprecipitated under these conditions had a molecular mass of 97 kDa and was phosphorylated on serine (Fig. 6B) phosphoprotein is a major component of the immune complex. Previous reports on the association of PtdsIns 3-kinase activity with receptors or oncoproteins have also shown that a phosphotyrosine-containing protein has a critical role in the formation of the complex (48-51). We therefore analyzed entire reaction mixtures from in vitro protein kinase assays of antiserum A immunoprecipitates and found them to contain phosphoserine and phosphothreonine but no phosphotyrosine (data not shown). We also found no phosphotyrosine by immunoblotting antiserum A immunoprecipitates with anti-phosphotyrosine antiserum (32) . When pp6Oc-src was immunoprecipitated from platelets by Mab 327, autophosphorylated in vitro, and subjected to phospho amino acid analysis, we found only phosphotyrosine (Fig. 5) . Therefore, the absence of phosphotyrosine in antiserum A immunoprecipitates was not due to an inability to recover phosphotyrosine under the conditions used. Anti-phosphotyrosine immunoprecipitates from platelet lysates were also assayed for PtdIns kinase activity. PtdIns kinase activity was increased 2-to 4-fold with thrombin treatment of platelets. However, these immunoprecipitates contained 10-20 times less PtdIns kinase activity compared with antiserum A immunoprecipitates.
We (34) . Coimmunoprecipitated with the Ptdlns 3-kinase was a protein-serine/threonine kinase. Complex formation was stimulated in lysates from thrombintreated platelets.
While antiserum A used in the experiments was obtained by immunizing a rabbit with a peptide from the PDGF receptor, the antigen does not appear to be the PDGF receptor. The amino acid sequence of the mouse PDGF-/3 receptor used as the immunogen (residues 958-977) does not resemble that of other known receptors or tyrosine kinases that form complexes with Ptdlns 3-kinase. No specific proteins were recognized by antiserum A in immunoblot assays or by Coomassie staining after SDS/PAGE; however, a 97-kDa phosphoprotein was immunoprecipitated from 32p_ labeled platelets, suggesting that a 97-kDa protein is one component of the complex. Antiserum A may be directed against Ptdlns 3-kinase or the serine/threonine kinase present in the complex, provided that one of these proteins or some other protein in the complex can respond to stimulation of platelets by thrombin. The stimulation of complex formation by thrombin suggests the possibility that antiserum A may recognize the thrombin receptor itself. Further studies will require purification of the platelet antigen(s) that complexes with the PtdIns 3-kinase.
Our work also demonstrates that a serine/threonine kinase is active during the formation of the immune complex.
Whether the 60-kDa protein phosphorylated in intact platelets represents the autophosphorylated kinase or a substrate phosphorylated by an associated kinase remains to be determined. There are at least two other examples of serine/ threonine kinases associating with Ptdlns 3-kinase and cellular receptors. One recent study (48) reported the association of a serine/threonine kinase with complexes containing Ptdlns 3-kinase, the activated PDGF receptor, and an 85-kDa phosphoprotein that may be the Ptdlns 3-kinase (48, 53) . Another report (25) demonstrates that the 74-kDa serine/ threonine kinase protooncogene product Raf-1 associates with the activated PDGF receptor and shows increased serine/threonine kinase activity upon complex formation. Immunoprecipitation of thrombin-stimulated Ptdlns kinase with antiserum A does not depend on tyrosine phosphorylation. Immunoprecipitations using several anti-phosphotyrosine antibodies demonstrated low levels of Ptdlns kinase activity comparable to that observed by Gutkind et al. (52) . While a role for tyrosine phosphorylation in the formation of complexes in platelets is impossible to exclude, phosphotyrosine-containing proteins were not detected in the complexes. Thus the mechanism of formation of complexes containing Ptdlns 3-kinase in platelets may be different from those described in other systems.
Previous studies of complex formation of Ptdlns 3-kinase with receptors have concentrated on receptors that evoke growth responses. Stimulation of complex formation in response to thrombin in platelets implies that 3-phosphate-
